1 Market Overview

1.1 Product Overview and Scope of Oncolytic Virus Therapy

1.2 Classification of Oncolytic Virus Therapy by Type

1.2.1 Overview: Global Oncolytic Virus Therapy Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Oncolytic Virus Therapy Revenue Market Share by Type in 2020

1.2.3 HSV-based Oncolytic Viruses

1.2.4 Adenoviruses-based Oncolytic Viruses

1.2.5 Vaccinia Virus-based Oncolytic Viruses

1.2.6 Vesicular Stomatitis Virus-based Oncolytic Viruses

1.2.7 Newcastle Disease Virus-based Oncolytic Viruses

1.3 Global Oncolytic Virus Therapy Market by Application

1.3.1 Overview: Global Oncolytic Virus Therapy Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Melanoma

1.3.3 Prostate Cancer

1.3.4 Breast Cancer

1.3.5 Ovarian Cancer

1.3.6 Others

1.4 Global Oncolytic Virus Therapy Market Size & Forecast

1.5 Global Oncolytic Virus Therapy Market Size and Forecast by Region

1.5.1 Global Oncolytic Virus Therapy Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Oncolytic Virus Therapy Market Size by Region, (2016-2021)

1.5.3 North America Oncolytic Virus Therapy Market Size and Prospect (2016-2026)

1.5.4 Europe Oncolytic Virus Therapy Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Oncolytic Virus Therapy Market Size and Prospect (2016-2026)

1.5.6 South America Oncolytic Virus Therapy Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Oncolytic Virus Therapy Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Oncolytic Virus Therapy Market Drivers

1.6.2 Oncolytic Virus Therapy Market Restraints

1.6.3 Oncolytic Virus Therapy Trends Analysis

2 Company Profiles

2.1 Amgen

2.1.1 Amgen Details

2.1.2 Amgen Major Business

2.1.3 Amgen Oncolytic Virus Therapy Product and Solutions

2.1.4 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Amgen Recent Developments and Future Plans

2.2 Oncolytics Biotech

2.2.1 Oncolytics Biotech Details

2.2.2 Oncolytics Biotech Major Business

2.2.3 Oncolytics Biotech Oncolytic Virus Therapy Product and Solutions

2.2.4 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Oncolytics Biotech Recent Developments and Future Plans

2.3 Viralytics

2.3.1 Viralytics Details

2.3.2 Viralytics Major Business

2.3.3 Viralytics Oncolytic Virus Therapy Product and Solutions

2.3.4 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Viralytics Recent Developments and Future Plans

2.4 Transgene SA

2.4.1 Transgene SA Details

2.4.2 Transgene SA Major Business

2.4.3 Transgene SA Oncolytic Virus Therapy Product and Solutions

2.4.4 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Transgene SA Recent Developments and Future Plans

2.5 Oncolys BioPharma

2.5.1 Oncolys BioPharma Details

2.5.2 Oncolys BioPharma Major Business

2.5.3 Oncolys BioPharma Oncolytic Virus Therapy Product and Solutions

2.5.4 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Oncolys BioPharma Recent Developments and Future Plans

2.6 Targovax

2.6.1 Targovax Details

2.6.2 Targovax Major Business

2.6.3 Targovax Oncolytic Virus Therapy Product and Solutions

2.6.4 Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Targovax Recent Developments and Future Plans

2.7 PsiOxus Therapeutics

2.7.1 PsiOxus Therapeutics Details

2.7.2 PsiOxus Therapeutics Major Business

2.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Product and Solutions

2.7.4 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 PsiOxus Therapeutics Recent Developments and Future Plans

2.8 SillaJen Biotherapeutics

2.8.1 SillaJen Biotherapeutics Details

2.8.2 SillaJen Biotherapeutics Major Business

2.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Product and Solutions

2.8.4 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 SillaJen Biotherapeutics Recent Developments and Future Plans

2.9 Sorrento Therapeutics

2.9.1 Sorrento Therapeutics Details

2.9.2 Sorrento Therapeutics Major Business

2.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Product and Solutions

2.9.4 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Sorrento Therapeutics Recent Developments and Future Plans

2.10 Lokon Pharma

2.10.1 Lokon Pharma Details

2.10.2 Lokon Pharma Major Business

2.10.3 Lokon Pharma Oncolytic Virus Therapy Product and Solutions

2.10.4 Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Lokon Pharma Recent Developments and Future Plans

2.11 Genelux Corporation

2.11.1 Genelux Corporation Details

2.11.2 Genelux Corporation Major Business

2.11.3 Genelux Corporation Oncolytic Virus Therapy Product and Solutions

2.11.4 Genelux Corporation Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Genelux Corporation Recent Developments and Future Plans

2.12 Vyriad

2.12.1 Vyriad Details

2.12.2 Vyriad Major Business

2.12.3 Vyriad Oncolytic Virus Therapy Product and Solutions

2.12.4 Vyriad Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Vyriad Recent Developments and Future Plans

2.13 TILT Biotherapeutics

2.13.1 TILT Biotherapeutics Details

2.13.2 TILT Biotherapeutics Major Business

2.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Product and Solutions

2.13.4 TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 TILT Biotherapeutics Recent Developments and Future Plans

2.14 Cold Genesys

2.14.1 Cold Genesys Details

2.14.2 Cold Genesys Major Business

2.14.3 Cold Genesys Oncolytic Virus Therapy Product and Solutions

2.14.4 Cold Genesys Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Cold Genesys Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Oncolytic Virus Therapy Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Oncolytic Virus Therapy Players Market Share

3.2.2 Top 10 Oncolytic Virus Therapy Players Market Share

3.2.3 Market Competition Trend

3.3 Oncolytic Virus Therapy Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Oncolytic Virus Therapy Revenue and Market Share by Type (2016-2021)

4.2 Global Oncolytic Virus Therapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Oncolytic Virus Therapy Revenue Market Share by Application (2016-2021)

5.2 Oncolytic Virus Therapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Oncolytic Virus Therapy Revenue by Type (2016-2026)

6.2 North America Oncolytic Virus Therapy Revenue by Application (2016-2026)

6.3 North America Oncolytic Virus Therapy Market Size by Country

6.3.1 North America Oncolytic Virus Therapy Revenue by Country (2016-2026)

6.3.2 United States Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

6.3.3 Canada Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

6.3.4 Mexico Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Oncolytic Virus Therapy Revenue by Type (2016-2026)

7.2 Europe Oncolytic Virus Therapy Revenue by Application (2016-2026)

7.3 Europe Oncolytic Virus Therapy Market Size by Country

7.3.1 Europe Oncolytic Virus Therapy Revenue by Country (2016-2026)

7.3.2 Germany Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

7.3.3 France Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

7.3.5 Russia Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

7.3.6 Italy Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Oncolytic Virus Therapy Revenue by Type (2016-2026)

8.2 Asia-Pacific Oncolytic Virus Therapy Revenue by Application (2016-2026)

8.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Region

8.3.1 Asia-Pacific Oncolytic Virus Therapy Revenue by Region (2016-2026)

8.3.2 China Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

8.3.3 Japan Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

8.3.4 South Korea Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

8.3.5 India Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

8.3.7 Australia Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Oncolytic Virus Therapy Revenue by Type (2016-2026)

9.2 South America Oncolytic Virus Therapy Revenue by Application (2016-2026)

9.3 South America Oncolytic Virus Therapy Market Size by Country

9.3.1 South America Oncolytic Virus Therapy Revenue by Country (2016-2026)

9.3.2 Brazil Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

9.3.3 Argentina Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Oncolytic Virus Therapy Revenue by Type (2016-2026)

10.2 Middle East & Africa Oncolytic Virus Therapy Revenue by Application (2016-2026)

10.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Country

10.3.1 Middle East & Africa Oncolytic Virus Therapy Revenue by Country (2016-2026)

10.3.2 Turkey Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

10.3.4 UAE Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Oncolytic Virus Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Oncolytic Virus Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Oncolytic Virus Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Oncolytic Virus Therapy Revenue (USD Million) by Region (2016-2021)

Table 5. Global Oncolytic Virus Therapy Revenue Market Share by Region (2021-2026)

Table 6. Amgen Corporate Information, Head Office, and Major Competitors

Table 7. Amgen Major Business

Table 8. Amgen Oncolytic Virus Therapy Product and Solutions

Table 9. Amgen Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Oncolytics Biotech Corporate Information, Head Office, and Major Competitors

Table 11. Oncolytics Biotech Major Business

Table 12. Oncolytics Biotech Oncolytic Virus Therapy Product and Solutions

Table 13. Oncolytics Biotech Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Viralytics Corporate Information, Head Office, and Major Competitors

Table 15. Viralytics Major Business

Table 16. Viralytics Oncolytic Virus Therapy Product and Solutions

Table 17. Viralytics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Transgene SA Corporate Information, Head Office, and Major Competitors

Table 19. Transgene SA Major Business

Table 20. Transgene SA Oncolytic Virus Therapy Product and Solutions

Table 21. Transgene SA Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Oncolys BioPharma Corporate Information, Head Office, and Major Competitors

Table 23. Oncolys BioPharma Major Business

Table 24. Oncolys BioPharma Oncolytic Virus Therapy Product and Solutions

Table 25. Oncolys BioPharma Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Targovax Corporate Information, Head Office, and Major Competitors

Table 27. Targovax Major Business

Table 28. Targovax Oncolytic Virus Therapy Product and Solutions

Table 29. Targovax Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. PsiOxus Therapeutics Corporate Information, Head Office, and Major Competitors

Table 31. PsiOxus Therapeutics Major Business

Table 32. PsiOxus Therapeutics Oncolytic Virus Therapy Product and Solutions

Table 33. PsiOxus Therapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. SillaJen Biotherapeutics Corporate Information, Head Office, and Major Competitors

Table 35. SillaJen Biotherapeutics Major Business

Table 36. SillaJen Biotherapeutics Oncolytic Virus Therapy Product and Solutions

Table 37. SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Sorrento Therapeutics Corporate Information, Head Office, and Major Competitors

Table 39. Sorrento Therapeutics Major Business

Table 40. Sorrento Therapeutics Oncolytic Virus Therapy Product and Solutions

Table 41. Sorrento Therapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Lokon Pharma Corporate Information, Head Office, and Major Competitors

Table 43. Lokon Pharma Major Business

Table 44. Lokon Pharma Oncolytic Virus Therapy Product and Solutions

Table 45. Lokon Pharma Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Genelux Corporation Corporate Information, Head Office, and Major Competitors

Table 47. Genelux Corporation Major Business

Table 48. Genelux Corporation Oncolytic Virus Therapy Product and Solutions

Table 49. Genelux Corporation Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Vyriad Corporate Information, Head Office, and Major Competitors

Table 51. Vyriad Major Business

Table 52. Vyriad Oncolytic Virus Therapy Product and Solutions

Table 53. Vyriad Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. TILT Biotherapeutics Corporate Information, Head Office, and Major Competitors

Table 55. TILT Biotherapeutics Major Business

Table 56. TILT Biotherapeutics Oncolytic Virus Therapy Product and Solutions

Table 57. TILT Biotherapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Cold Genesys Corporate Information, Head Office, and Major Competitors

Table 59. Cold Genesys Major Business

Table 60. Cold Genesys Oncolytic Virus Therapy Product and Solutions

Table 61. Cold Genesys Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Global Oncolytic Virus Therapy Revenue (USD Million) by Players (2019-2021)

Table 63. Global Oncolytic Virus Therapy Revenue Share by Players (2019-2021)

Table 64. Breakdown of Oncolytic Virus Therapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 65. Oncolytic Virus Therapy Players Head Office, Products and Services Provided

Table 66. Oncolytic Virus Therapy Mergers & Acquisitions in the Past Five Years

Table 67. Oncolytic Virus Therapy New Entrants and Expansion Plans

Table 68. Global Oncolytic Virus Therapy Revenue (USD Million) by Type (2016-2021)

Table 69. Global Oncolytic Virus Therapy Revenue Share by Type (2016-2021)

Table 70. Global Oncolytic Virus Therapy Revenue Forecast by Type (2021-2026)

Table 71. Global Oncolytic Virus Therapy Revenue by Application (2016-2021)

Table 72. Global Oncolytic Virus Therapy Revenue Forecast by Application (2021-2026)

Table 73. North America Oncolytic Virus Therapy Revenue by Type (2016-2021) & (USD Million)

Table 74. North America Oncolytic Virus Therapy Revenue by Type (2021-2026) & (USD Million)

Table 75. North America Oncolytic Virus Therapy Revenue by Application (2016-2021) & (USD Million)

Table 76. North America Oncolytic Virus Therapy Revenue by Application (2021-2026) & (USD Million)

Table 77. North America Oncolytic Virus Therapy Revenue by Country (2016-2021) & (USD Million)

Table 78. North America Oncolytic Virus Therapy Revenue by Country (2021-2026) & (USD Million)

Table 79. Europe Oncolytic Virus Therapy Revenue by Type (2016-2021) & (USD Million)

Table 80. Europe Oncolytic Virus Therapy Revenue by Type (2021-2026) & (USD Million)

Table 81. Europe Oncolytic Virus Therapy Revenue by Application (2016-2021) & (USD Million)

Table 82. Europe Oncolytic Virus Therapy Revenue by Application (2021-2026) & (USD Million)

Table 83. Europe Oncolytic Virus Therapy Revenue by Country (2016-2021) & (USD Million)

Table 84. Europe Oncolytic Virus Therapy Revenue by Country (2021-2026) & (USD Million)

Table 85. Asia-Pacific Oncolytic Virus Therapy Revenue by Type (2016-2021) & (USD Million)

Table 86. Asia-Pacific Oncolytic Virus Therapy Revenue by Type (2021-2026) & (USD Million)

Table 87. Asia-Pacific Oncolytic Virus Therapy Revenue by Application (2016-2021) & (USD Million)

Table 88. Asia-Pacific Oncolytic Virus Therapy Revenue by Application (2021-2026) & (USD Million)

Table 89. Asia-Pacific Oncolytic Virus Therapy Revenue by Region (2016-2021) & (USD Million)

Table 90. Asia-Pacific Oncolytic Virus Therapy Revenue by Region (2021-2026) & (USD Million)

Table 91. South America Oncolytic Virus Therapy Revenue by Type (2016-2021) & (USD Million)

Table 92. South America Oncolytic Virus Therapy Revenue by Type (2021-2026) & (USD Million)

Table 93. South America Oncolytic Virus Therapy Revenue by Application (2016-2021) & (USD Million)

Table 94. South America Oncolytic Virus Therapy Revenue by Application (2021-2026) & (USD Million)

Table 95. South America Oncolytic Virus Therapy Revenue by Country (2016-2021) & (USD Million)

Table 96. South America Oncolytic Virus Therapy Revenue by Country (2021-2026) & (USD Million)

Table 97. Middle East & Africa Oncolytic Virus Therapy Revenue by Type (2016-2021) & (USD Million)

Table 98. Middle East & Africa Oncolytic Virus Therapy Revenue by Type (2021-2026) & (USD Million)

Table 99. Middle East & Africa Oncolytic Virus Therapy Revenue by Application (2016-2021) & (USD Million)

Table 100. Middle East & Africa Oncolytic Virus Therapy Revenue by Application (2021-2026) & (USD Million)

Table 101. Middle East & Africa Oncolytic Virus Therapy Revenue by Country (2016-2021) & (USD Million)

Table 102. Middle East & Africa Oncolytic Virus Therapy Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Oncolytic Virus Therapy Picture

Figure 2. Global Oncolytic Virus Therapy Revenue Market Share by Type in 2020

Figure 3. HSV-based Oncolytic Viruses

Figure 4. Adenoviruses-based Oncolytic Viruses

Figure 5. Vaccinia Virus-based Oncolytic Viruses

Figure 6. Vesicular Stomatitis Virus-based Oncolytic Viruses

Figure 7. Newcastle Disease Virus-based Oncolytic Viruses

Figure 8. Oncolytic Virus Therapy Revenue Market Share by Application in 2020

Figure 9. Melanoma Picture

Figure 10. Prostate Cancer Picture

Figure 11. Breast Cancer Picture

Figure 12. Ovarian Cancer Picture

Figure 13. Others Picture

Figure 14. Global Oncolytic Virus Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 15. Global Oncolytic Virus Therapy Revenue and Forecast (2016-2026) & (USD Million)

Figure 16. Global Oncolytic Virus Therapy Revenue Market Share by Region (2016-2026)

Figure 17. Global Oncolytic Virus Therapy Revenue Market Share by Region in 2020

Figure 18. North America Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Europe Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Asia-Pacific Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. South America Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Middle East and Africa Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. Oncolytic Virus Therapy Market Drivers

Figure 24. Oncolytic Virus Therapy Market Restraints

Figure 25. Oncolytic Virus Therapy Market Trends

Figure 26. Amgen Recent Developments and Future Plans

Figure 27. Oncolytics Biotech Recent Developments and Future Plans

Figure 28. Viralytics Recent Developments and Future Plans

Figure 29. Transgene SA Recent Developments and Future Plans

Figure 30. Oncolys BioPharma Recent Developments and Future Plans

Figure 31. Targovax Recent Developments and Future Plans

Figure 32. PsiOxus Therapeutics Recent Developments and Future Plans

Figure 33. SillaJen Biotherapeutics Recent Developments and Future Plans

Figure 34. Sorrento Therapeutics Recent Developments and Future Plans

Figure 35. Lokon Pharma Recent Developments and Future Plans

Figure 36. Genelux Corporation Recent Developments and Future Plans

Figure 37. Vyriad Recent Developments and Future Plans

Figure 38. TILT Biotherapeutics Recent Developments and Future Plans

Figure 39. Cold Genesys Recent Developments and Future Plans

Figure 40. Global Oncolytic Virus Therapy Revenue Share by Players in 2020

Figure 41. Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 42. Global Top 3 Players Oncolytic Virus Therapy Revenue Market Share in 2020

Figure 43. Global Top 10 Players Oncolytic Virus Therapy Revenue Market Share in 2020

Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 45. Global Oncolytic Virus Therapy Revenue Share by Type in 2020

Figure 46. Global Oncolytic Virus Therapy Market Share Forecast by Type (2021-2026)

Figure 47. Global Oncolytic Virus Therapy Revenue Share by Application in 2020

Figure 48. Global Oncolytic Virus Therapy Market Share Forecast by Application (2021-2026)

Figure 49. North America Oncolytic Virus Therapy Sales Market Share by Type (2016-2026)

Figure 50. North America Oncolytic Virus Therapy Sales Market Share by Application (2016-2026)

Figure 51. North America Oncolytic Virus Therapy Revenue Market Share by Country (2016-2026)

Figure 52. United States Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Canada Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Mexico Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Europe Oncolytic Virus Therapy Sales Market Share by Type (2016-2026)

Figure 56. Europe Oncolytic Virus Therapy Sales Market Share by Application (2016-2026)

Figure 57. Europe Oncolytic Virus Therapy Revenue Market Share by Country (2016-2026)

Figure 58. Germany Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. France Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. United Kingdom Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Russia Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Italy Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Asia-Pacific Oncolytic Virus Therapy Sales Market Share by Type (2016-2026)

Figure 64. Asia-Pacific Oncolytic Virus Therapy Sales Market Share by Application (2016-2026)

Figure 65. Asia-Pacific Oncolytic Virus Therapy Revenue Market Share by Region (2016-2026)

Figure 66. China Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Japan Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South Korea Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. India Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Southeast Asia Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Australia Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. South America Oncolytic Virus Therapy Sales Market Share by Type (2016-2026)

Figure 73. South America Oncolytic Virus Therapy Sales Market Share by Application (2016-2026)

Figure 74. South America Oncolytic Virus Therapy Revenue Market Share by Country (2016-2026)

Figure 75. Brazil Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Argentina Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Middle East and Africa Oncolytic Virus Therapy Sales Market Share by Type (2016-2026)

Figure 78. Middle East and Africa Oncolytic Virus Therapy Sales Market Share by Application (2016-2026)

Figure 79. Middle East and Africa Oncolytic Virus Therapy Revenue Market Share by Country (2016-2026)

Figure 80. Turkey Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Saudi Arabia Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. UAE Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. Methodology

Figure 84. Research Process and Data Source